BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26487692)

  • 1. Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors.
    Son SH; Goo YH; Choi M; Saha PK; Oka K; Chan LC; Paul A
    Cardiovasc Res; 2016 Feb; 109(2):294-304. PubMed ID: 26487692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells.
    Bielicki JK; McCall MR; Forte TM
    J Lipid Res; 1999 Jan; 40(1):85-92. PubMed ID: 9869653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
    Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible protein 2 Hig2/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice.
    Maier A; Wu H; Cordasic N; Oefner P; Dietel B; Thiele C; Weidemann A; Eckardt KU; Warnecke C
    FASEB J; 2017 Nov; 31(11):4971-4984. PubMed ID: 28760743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perilipin 2 (PLIN2)-deficiency does not increase cholesterol-induced toxicity in macrophages.
    Son SH; Goo YH; Chang BH; Paul A
    PLoS One; 2012; 7(3):e33063. PubMed ID: 22427949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression.
    Thorngate FE; Yancey PG; Kellner-Weibel G; Rudel LL; Rothblat GH; Williams DL
    J Lipid Res; 2003 Dec; 44(12):2331-8. PubMed ID: 12951361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1.
    Lv YC; Tang YY; Peng J; Zhao GJ; Yang J; Yao F; Ouyang XP; He PP; Xie W; Tan YL; Zhang M; Liu D; Tang DP; Cayabyab FS; Zheng XL; Zhang DW; Tian GP; Tang CK
    Atherosclerosis; 2014 Sep; 236(1):215-26. PubMed ID: 25084135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.
    Lorenzi I; von Eckardstein A; Cavelier C; Radosavljevic S; Rohrer L
    J Mol Med (Berl); 2008 Feb; 86(2):171-83. PubMed ID: 17906976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I stimulates secretion of apolipoprotein E by foam cell macrophages.
    Rees D; Sloane T; Jessup W; Dean RT; Kritharides L
    J Biol Chem; 1999 Sep; 274(39):27925-33. PubMed ID: 10488140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of endogenous phospholipid transfer protein impairs ABCA1-dependent efflux of cholesterol from macrophage foam cells.
    Lee-Rueckert M; Vikstedt R; Metso J; Ehnholm C; Kovanen PT; Jauhiainen M
    J Lipid Res; 2006 Aug; 47(8):1725-32. PubMed ID: 16687660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux.
    Kockx M; Rye KA; Gaus K; Quinn CM; Wright J; Sloane T; Sviridov D; Fu Y; Sullivan D; Burnett JR; Rust S; Assmann G; Anantharamaiah GM; Palgunachari MN; Katz SL; Phillips MC; Dean RT; Jessup W; Kritharides L
    J Biol Chem; 2004 Jun; 279(25):25966-77. PubMed ID: 15066991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.
    Yvan-Charvet L; Ranalletta M; Wang N; Han S; Terasaka N; Li R; Welch C; Tall AR
    J Clin Invest; 2007 Dec; 117(12):3900-8. PubMed ID: 17992262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake.
    Pollard RD; Blesso CN; Zabalawi M; Fulp B; Gerelus M; Zhu X; Lyons EW; Nuradin N; Francone OL; Li XA; Sahoo D; Thomas MJ; Sorci-Thomas MG
    J Biol Chem; 2015 Jun; 290(25):15496-15511. PubMed ID: 25947382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype.
    Taylor JM; Allen AM; Graham A
    Clin Sci (Lond); 2014 Nov; 127(10):603-13. PubMed ID: 24814875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased atherosclerosis in P2Y13/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transport.
    Lichtenstein L; Serhan N; Espinosa-Delgado S; Fabre A; Annema W; Tietge UJ; Robaye B; Boeynaems JM; Laffargue M; Perret B; Martinez LO
    Cardiovasc Res; 2015 May; 106(2):314-23. PubMed ID: 25770145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL inhibits the mediation of cholesterol efflux from macrophage foam cells by apoA-I-containing lipoproteins. A putative mechanism for foam cell formation.
    Nakamura R; Ohta T; Ikeda Y; Matsuda I
    Arterioscler Thromb; 1993 Sep; 13(9):1307-16. PubMed ID: 8364015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL is essential for atherosclerotic lesion regression in Apoe knockout mice by bone marrow Apoe reconstitution.
    van der Sluis RJ; Verwilligen RAF; Lendvai Z; Wever R; Hoekstra M; Van Eck M
    Atherosclerosis; 2018 Nov; 278():240-249. PubMed ID: 30340108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages.
    Langer C; Huang Y; Cullen P; Wiesenhütter B; Mahley RW; Assmann G; von Eckardstein A
    J Mol Med (Berl); 2000; 78(4):217-27. PubMed ID: 10933584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
    Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.